VIDI SYMPOSIUM

16
VIDI SYMPOSIUM Criteria Influencing Potential Impact of HIV Prevention Interventions January 14, 2008 Thomas Fleming, PhD University of Washington Fred Hutchinson Cancer Center

description

VIDI SYMPOSIUM. Criteria Influencing Potential Impact of HIV Prevention Interventions January 14, 2008 Thomas Fleming, PhD University of Washington Fred Hutchinson Cancer Center. Percent of HIV transmission risk being addressed ~ Size of the risk group: fraction of the incidence - PowerPoint PPT Presentation

Transcript of VIDI SYMPOSIUM

Page 1: VIDI SYMPOSIUM

VIDI SYMPOSIUM

Criteria Influencing Potential Impact of HIV Prevention Interventions

January 14, 2008

Thomas Fleming, PhDUniversity of Washington

Fred Hutchinson Cancer Center

Page 2: VIDI SYMPOSIUM

1. Percent of HIV transmission risk being addressed

~ Size of the risk group: fraction of the incidence ~ Attributable risk of transmission pathway addressed ~ Potential for reduction in secondary transmission

2. Intervention: Plausible Reduction in Relative Risk

~ Strength of “proof of concept” data ~ Likelihood for effect on secondary transmission

3. Feasible level of coverage of the target population ~ Affordability, Acceptability, Practicality

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 3: VIDI SYMPOSIUM
Page 4: VIDI SYMPOSIUM

~ 27% : Black/Hispanic MSM ~ 16% : Black/Hispanic Non-MSM

→ 7% heterosexual ; 9% IDU ~ 24% : White MSM ~ 3% : White Non-MSM Men

→ 1% heterosexual ; 2% IDU

~ 19% : Black/Hispanic Women (Heterosexual) ~ 5% : Black/Hispanic Women (Non-Heterosex)

→ IDU ~ 4% : White Women (Heterosexual) ~ 2% : White Women (Non-Heterosexual)

Size of the Risk Groups Fraction of the US Incidence

Page 5: VIDI SYMPOSIUM

1. Percent of HIV transmission risk being addressed

~ Size of the risk group: fraction of the incidence ~ Attributable risk of transmission pathway addressed ~ Potential for reduction in secondary transmission

2. Intervention: Plausible Reduction in Relative Risk

~ Strength of “proof of concept” data ~ Likelihood for effect on secondary transmission

3. Feasible level of coverage of the target population ~ Affordability, Acceptability, Practicality

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 6: VIDI SYMPOSIUM

Hypothetical Example ↓ in Substance Use in MSM

1. % of Tx risk addressed 11.25K (25% US incidence)

~ Size of risk group ~ 22.5K MSM ~ Attributable risk ~ 50% of MSM Tx ~ ↓ in secondary tx ( + )

2. Plausible ↓ in RR 4.5K (10% US incidence)

~ Established POC? ~ Expect 40% ↓ in risk ~ ↓ in secondary tx ( ─ )

3. Feasible coverage 2.25K (5% US Incidence) ~ Practical, Affordable? ~ Expect 50% coverage

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 7: VIDI SYMPOSIUM

1. Percent of HIV transmission risk being addressed

~ Size of the risk group: fraction of the incidence ~ Attributable risk of transmission pathway addressed ~ Potential for reduction in secondary transmission

2. Intervention: Plausible Reduction in Relative Risk

~ Strength of “proof of concept” data ~ Likelihood for effect on secondary transmission

3. Feasible level of coverage of the target population ~ Affordability, Acceptability, Practicality

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 8: VIDI SYMPOSIUM

Hypothetical Example ↓ in Substance Use in MSM

1. % of Tx risk addressed 11.25K (25% US incidence)

~ Size of risk group ~ 22.5K MSM ~ Attributable risk ~ 50% of MSM Tx ~ ↓ in secondary tx ( + )

2. Plausible ↓ in RR 4.5K (10% US incidence)

~ Established POC? ~ Expect 40% ↓ in risk ~ ↓ in secondary tx ( ─ )

3. Feasible coverage 2.25K (5% US Incidence) ~ Practical, Affordable? ~ Expect 50% coverage

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 9: VIDI SYMPOSIUM

1. Percent of HIV transmission risk being addressed

~ Size of the risk group: fraction of the incidence ~ Attributable risk of transmission pathway addressed ~ Potential for reduction in secondary transmission

2. Intervention: Plausible Reduction in Relative Risk

~ Strength of “proof of concept” data ~ Likelihood for effect on secondary transmission

3. Feasible level of coverage of the target population ~ Affordability, Acceptability, Practicality

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 10: VIDI SYMPOSIUM

Hypothetical Example ↓ in Substance Use in MSM

1. % of Tx risk addressed 11.25K (25% US incidence)

~ Size of risk group ~ 22.5K MSM ~ Attributable risk ~ 50% of MSM Tx ~ ↓ in secondary tx ( + )

2. Plausible ↓ in RR 4.5K (10% US incidence)

~ Established POC? ~ Expect 40% ↓ in risk ~ ↓ in secondary tx ( ─ )

3. Feasible coverage 2.25K (5% US Incidence) ~ Practical, Affordable? ~ Expect 50% coverage

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 11: VIDI SYMPOSIUM

1. Percent of HIV transmission risk being addressed

~ Size of the risk group: fraction of the incidence ~ Attributable risk of transmission pathway addressed ~ Potential for reduction in secondary transmission

2. Intervention: Plausible Reduction in Relative Risk

~ Strength of “proof of concept” data ~ Likelihood for effect on secondary transmission

3. Feasible level of coverage of the target population ~ Affordability, Acceptability, Practicality

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 12: VIDI SYMPOSIUM

Hypothetical Example ↓ in Substance Use in MSM

1. % of Tx risk addressed 11.25K (25% US incidence)

~ Size of risk group ~ 22.5K MSM ~ Attributable risk ~ 50% of MSM Tx ~ ↓ in secondary tx ( + )

2. Plausible ↓ in RR 4.5K (10% US incidence)

~ Established POC? ~ Expect 40% ↓ in risk ~ ↓ in secondary tx ( ─ )

3. Feasible coverage 2.25K (5% US Incidence) ~ Practical, Affordable? ~ Expect 50% coverage

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 13: VIDI SYMPOSIUM

Illustrations Vaccine MCT ART 012, 046 052, 060 , Voice

1. % of Tx risk addressed

~ Size of risk group ++ + + ~ Attributable risk ++ ++ ++ ~ ↓ in secondary tx (+/─) ( ─ ) (+/─)

2. Efficacy of intervention

~ Established POC? ? ++ ? ~ ↓ in secondary tx ( ? ) ( ─ ) ( ? )

3. Feasible coverage ~ Practical, Affordable? + +/─ +

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 14: VIDI SYMPOSIUM

~ 27% : Black/Hispanic MSM ~ 16% : Black/Hispanic Non-MSM

→ 7% heterosexual ; 9% IDU ~ 24% : White MSM ~ 3% : White Non-MSM Men

→ 1% heterosexual ; 2% IDU

~ 19% : Black/Hispanic Women: Heterosexual ~ 5% : Black/Hispanic Women: IDU

~ 4% : White Women: Heterosexual ~ 2% : White Women: IDU

Size of the Risk Groups Fraction of the US Incidence

Page 15: VIDI SYMPOSIUM

1. Percent of HIV transmission risk being addressed

~ Size of the risk group: fraction of the incidence ~ Attributable risk of transmission pathway addressed ~ Potential for reduction in secondary transmission

2. Intervention: Plausible Reduction in Relative Risk

~ Strength of “proof of concept” data ~ Likelihood for effect on secondary transmission

3. Feasible level of coverage of the target population ~ Affordability, Acceptability, Practicality

Criteria Influencing Potential Impact of HIV Prevention Interventions

Page 16: VIDI SYMPOSIUM

VIDI SYMPOSIUM

The Way Forward for

HIV Prevention:

Combination Strategies (HAARP)

Domestic & International

Vaccines Microbicides

ART MCT

STD IDU

Behavioral